About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials | 7,497 Studies Recruiting

Clinical TrialsProstate Cancer

Prostate Cancer Clinical Trials

Browse 7,497 clinical trials for prostate cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3821-3840 of 7,497 trials

CompletedAndrocur Effects on Quality of LifeAndrocur is an antiandrogenic drug, which blocks the action of male sex hormones. Androcur is used for treatment of advanced prostate cancer.NCT00908674·Many Locations CompletedMultivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate CancerThis is a pilot trial designed to assess safety and immunogenicity of a multivalent conjugate vaccine for use in patients with biochemically relapsed prostate cancer.NCT00579423·New York, New York RecruitingObservational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.SOGUG-PRINCIS is a retrospective (regarding patient inclusion) and prospective follow-up, epidemiological, non-interventional, non-blinded, non-randomized, multicenter, national…NCT06724159·Albacete, Albacete and 83 others

Related Searches

prostate carcinomatrials

Data from ClinicalTrials.govTerms

CompletedA Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerThis is a phase II study designed to evaluate the potential clinical efficacy of thalidomide in patients with hormone-refractory prostate cancer.NCT00001446·Bethesda, Maryland

RecruitingEvaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung…NCT07080242·Huntsville, Alabama and 23 others

CompletedCCRO044: Quality of Life Assessments Associated With a Physician Communication Intervention for Prostate Cancer PatientsA generic cancer health-related quality of life measure will be used to assess the impact of the patient-specific radiation therapy plan review using the European Organisation for…NCT03780023·Sacramento, California

SuspendedThe Plenaxis® Experience StudyPraecis is currently conducting a 2000 patient Experience Study; this is a Phase IV commitment postmarketing safety study in the Food and Drug Administration (FDA) indicated…NCT00103623·Birmingham, Alabama and 59 others

Completed18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate CancerThe main purpose of this phase II trial study is to determine whether a positron emission tomography (PET)/computed tomography (CT) scan using 18F-DCFPyL affects the clinical…NCT04390880·Los Angeles, California

RecruitingDiscovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer PatientsPatients with cancers that are sensitive to radiotherapy treatment and/or patients who have experienced severe acute/ late side effects to radiotherapy will be recruited to the…NCT04340024·Singapore

RecruitingAVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncThe study aims to develop educational media interventions to prepare Latinx Spanish-speaking radiation oncology patients for a course of breast or prostate cancer radiation…NCT05351424·Miami Beach, Florida and 1 other

WithdrawnPhase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer PatientsThis is a phase 2, open-label, non-randomized, single-arm study in patients with high-risk PCa diagnosed with prostate biopsy and undergoing RP and ePLND.NCT04565496·Milan and 1 other

CompletedPlatelet Rich Plasma During Radical ProstatectomyCan platelet rich plasma applied to nerve bundles at time of surgery help the nerve bundles heal?NCT02957149·Rochester, Minnesota

Unknown68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese PatientsThis is a prospective, open-label, single-arm, multicenter bridging study in Chinese patients with prostate cancer.NCT05847348·Beijing and 7 others

Enrolling by invitationProphylactic Prostatectomy for Prostate Cancer (PPPC)Prostate cancer affects 1-in-8 people assigned male at birth in the UK and kills almost 12,000 annually. Half the cases occur due to genetic factors.NCT06470685·London

WithdrawnA Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to investigate radiographic progression-free survival (PFS) of enzalutamide in chemotherapy-naïve patients with progressive metastatic…NCT01663415

CompletedLapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone TherapyRATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.NCT00246753·Chapel Hill, North Carolina and 2 others

CompletedSipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate CancerThe purpose of this study is to find out what effects taking ipilimumab, as an immediate or delayed treatment, following completion of sipuleucel-T (SipT) treatment, has on…NCT01804465·San Francisco, California and 1 other

RecruitingDifferent Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancerde Novo metastatic prostate cancer with limited metastatic spread benefits from local radiotherapy to the prostate. Two different fractionation schedules will be tested.NCT04612907·Umeå

TerminatedCabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC)The purpose of this study is to determine what effects (good and bad) cabozantinib has in treatment of patients with metastatic castrate resistant prostate cancer (mCRPC).NCT04631744·New York, New York

CompletedThe Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate CancerObtain PSMA-PET imaging preoperatively and calculate performance for predicting extra-prostatic extension based on whole-mount pathology (gold standard).NCT04936334·Indianapolis, Indiana

PreviousPage 192 of 375Next